FitzPatrick Margaret M

SEC Form 4 insider trading activity

FitzPatrick Margaret M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.

On the most recent filing, FitzPatrick Margaret M is listed as Director at AN2 Therapeutics, Inc. Inside the rolling window, FitzPatrick Margaret M reported 1 open-market purchase totaling $12K in ANTX and no open-market sales.

Companies traded

Other insiders at ANTX

Insider Buying

$12K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANTX
FitzPatrick Margaret M
Purchase$12KSep 2SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has FitzPatrick Margaret M made?

FitzPatrick Margaret M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does FitzPatrick Margaret M trade?

FitzPatrick Margaret M has filed SEC Form 4 disclosures for 1 company, including ANTX.

When was FitzPatrick Margaret M's most recent SEC Form 4 filing?

FitzPatrick Margaret M's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.

What is FitzPatrick Margaret M's total buy and sell value in the current window?

Inside the rolling retention window, FitzPatrick Margaret M bought $12K and sold $0 based on SEC Form 4 filings.

What was FitzPatrick Margaret M's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,098 ANTX shares on 2026-09-01, worth $12K, per SEC Form 4 filings.